AT

Agomab Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Agomab Therapeutics at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
AT
Agomab Therapeutics
Ghent, Belgium
Biotech
Develops organ-restricted small molecules for fibrotic diseases, including fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis.
Panel
Mon Nov 9
14:00–14:45
Voices from the IPO Class of ’25/’26: What’s Next?
Leaders of biotechs that listed on the stock market in 2025 and 2026 describe life after going public and the hurdles they face.
with European Biotechnology Magazine, Andera Partners, HealthCap

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Agomab Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction